Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ferrante

Showing results (71-80 of 350) with videos related to

Pageof 35
Sort By:
Frontiers in Immunology|April 1, 2021
Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling PathwaysMarileen M Prins, Bram Verstockt, Marc Ferrante, et al.
Scandinavian Journal of Gastroenterology|May 21, 2019
Short Health Scale: a valid and reliable measure of quality of life in Dutch speaking patients with inflammatory bowel diseaseSofie Coenen, Ellen Weyts, Patricia Geens, et al.
Digestion|January 9, 2020
Update on the Management of Inflammatory Bowel Disease during Pregnancy and BreastfeedingSophie Restellini, Luc Biedermann, Petr Hruz, et al.
Gut|April 29, 2017
Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trialThomas Van Stappen, Niels Vande Casteele, Gert Van Assche, et al.
British Journal of Clinical Pharmacology|January 12, 2019
Optimising infliximab induction dosing for patients with ulcerative colitisErwin Dreesen, Ruben Faelens, Gert Van Assche, et al.
Inflammatory Bowel Diseases|March 15, 2006
Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's diseaseTibor Hlavaty, Philippe Persoons, Severine Vermeire, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 12, 2019
Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel DiseaseKaren van Hoeve, Erwin Dreesen, Ilse Hoffman, et al.
Journal of Crohn'S & Colitis|September 22, 2018
Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel DiseaseKaren van Hoeve, Erwin Dreesen, Ilse Hoffman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2006
Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitisDavid N Moskovitz, Gert Van Assche, Benedikte Maenhout, et al.
European Journal of Gastroenterology & Hepatology|October 30, 2015
Thromboembolism as an important complication of inflammatory bowel diseaseLize Bollen, Niels Vande Casteele, Vera Ballet, et al.
Pageof 35

Showing results (71-80 of 350) with videos related to

Sort By:
Pageof 35
Frontiers in Immunology|April 1, 2021
Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling PathwaysMarileen M Prins, Bram Verstockt, Marc Ferrante, et al.
Scandinavian Journal of Gastroenterology|May 21, 2019
Short Health Scale: a valid and reliable measure of quality of life in Dutch speaking patients with inflammatory bowel diseaseSofie Coenen, Ellen Weyts, Patricia Geens, et al.
Digestion|January 9, 2020
Update on the Management of Inflammatory Bowel Disease during Pregnancy and BreastfeedingSophie Restellini, Luc Biedermann, Petr Hruz, et al.
Gut|April 29, 2017
Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trialThomas Van Stappen, Niels Vande Casteele, Gert Van Assche, et al.
British Journal of Clinical Pharmacology|January 12, 2019
Optimising infliximab induction dosing for patients with ulcerative colitisErwin Dreesen, Ruben Faelens, Gert Van Assche, et al.
Inflammatory Bowel Diseases|March 15, 2006
Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's diseaseTibor Hlavaty, Philippe Persoons, Severine Vermeire, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 12, 2019
Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel DiseaseKaren van Hoeve, Erwin Dreesen, Ilse Hoffman, et al.
Journal of Crohn'S & Colitis|September 22, 2018
Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel DiseaseKaren van Hoeve, Erwin Dreesen, Ilse Hoffman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 24, 2006
Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitisDavid N Moskovitz, Gert Van Assche, Benedikte Maenhout, et al.
European Journal of Gastroenterology & Hepatology|October 30, 2015
Thromboembolism as an important complication of inflammatory bowel diseaseLize Bollen, Niels Vande Casteele, Vera Ballet, et al.
Pageof 35